Futurism on MSN20d
China's "Artificial Sun" Just Smashed the Record for Stable Fusion Reaction
which still lingers at fission reactors like the Fukushima Daiichi plant that melted down in 2011. "A fusion device must achieve stable operation at high efficiency for thousands of seconds to enable ...
pharmaphorum9d
The evolution of multichannel marketing into touchpoints
Unfortunately, though, pharma has so far been unsuccessful in using MCM to its full potential, says Thomas Listerman, lead digital implementation & multichannel DACH at Daiichi Sankyo.
ジャパンタイムズ13d
AstraZeneca and Daiichi’s breast cancer drug gets EU backing
In December, Astra and Daiichi withdrew an application in the EU for the drug to treat a type of lung cancer after feedback from regulatory advisers. Mixed results from a late-stage trial showed ...
Channel NewsAsia Singapore6d
IHH Healthcare's unit seeks up to $1.25 billion from Japan's Daiichi over Fortis deal
Malaysia's IHH Healthcare said on Thursday its unit is seeking compensation of up to 109.3 billion rupees ($1.25 billion) from Japan's Daiichi Sankyo for its stake buy in India's Fortis Healthcare.
pharmaphorum2d
Company Profile: Daiichi Sankyo
Disclaimer: This article has been developed and funded by Daiichi Sankyo. Daiichi Sankyo has more than 120 years of experience and scientific expertise. In 2019, they entered the oncology market ...
The Star6d
IHH seeks RM5.5bil from Japan’s Daiichi for Fortis deal
PETALING JAYA: IHH Healthcare Bhd says its unit is seeking compensation of up to 109.3 billion rupees (RM5.46bil) from Japan’s Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.
Reuters16d
Daiichi Sankyo Co Ltd
Malaysia's IHH Healthcare may be entitled to damages of up to $1.25 billion from Japan's Daiichi Sankyo for blocking its bid for control of Indian hospital operator Fortis , according to a report ...
Business Times6d
IHH unit may seek higher compensation in lawsuit against Japan’s Daiichi Sankyo over Fortis deal
To recap, NTK in October 2023 filed a lawsuit in the Tokyo District Court alleging that Daiichi Sankyo caused losses by preventing NTK from proceeding with open offers to buy a stake in Indian ...
Wall Street Journal1d
Daiichi Sankyo Co. Ltd. ADR
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
FiercePharma12d
Merck vaccine, Daiichi ADC win approval recommendations in busy week at EU's drug regulator
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP ...
Wall Street Journal3d
Daiichi Sankyo Co. Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...